Trial Profile

An Open-label, Multicentre, Single-arm Trial of Monthly Injections of Depot Buprenorphine in People With Opioid Dependence

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 05 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Buprenorphine (Primary)
Indications Opioid-related disorders
Focus Therapeutic Use
Acronyms CoLAB

Most Recent Events

30 Oct 2024 According to an Indivior media release, Results from this study were published in the International Journal of Drug Policy.
24 Jun 2021 According to an Indivior media release, data from this study presented at the Poster QA session in College on Problems of Drug Dependence (CPDD) 83rd Annual Scientific Virtual Meeting taking place June 21-24, 2021.
14 Nov 2019 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com